Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Bacteremia × Moxifloxacin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Neoplasms 2 Breast Neoplasms 2 Solid Tumours 1 Side-effect of Antibiotic 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Non-Hodgkin 1 Long QT Syndrome 1 Hot Flashes 1 Hodgkin Disease 1 Carcinoma, Renal Cell 1 Bacteremia 1 Advanced Breast Cancer 1

Interventions

telavancin 1 Moxifloxacin 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00398411 2015-06-29

MoxiProph

University of Cologne

Phase 3 Completed

66 enrolled 15 charts

LymphoidPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Bacteremia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡